Evidence map›Paper›PMID 32017988›Full record

ArticleBrain, behavior, and immunity2020

let-7g counteracts endothelial dysfunction and ameliorating neurological functions in mouse ischemia/reperfusion stroke model.

David L Bernstein, Sachin Gajghate, Nancy L Reichenbach, Malika Winfield, Yuri Persidsky, Nathan A Heldt, Slava Rom

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Orally bioavailable CBResearch square · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Biomedicines · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

David L BernsteinDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Sachin GajghateDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Nancy L ReichenbachDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Malika WinfieldDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Yuri PersidskyDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Nathan A HeldtDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Slava RomDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. Electronic address: srom@temple.edu.
Temple University · US

Funding

CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activationR37AA015913 · NIAAA · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI · 2010 to 2019
$3.6M
Blood brain barrier injury in HIV infection complicated by diabetes: Mechanisms and protective strategies preventing cognitive impairmentR01MH115786 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI · 2018 to 2022
$2.5M
Protective role of let-7 microRNAs in brain endothelial dysfunction during ischemia/reperfusion injuryR01NS101135 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI ROM, SLAVA · 2018 to 2022
$1.7M
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injuryR01AA015913 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PERSIDSKY, YURI · 2005 to 2009
$1.6M
NIAAA NIH HHS R01 AA015913NIAAA NIH HHS R37 AA015913NIMH NIH HHS R01 MH115786NINDS NIH HHS R01 NS101135
6 · The paper itself

Abstract

Stroke is a debilitating disease, accounting for almost 20% of all hospital visits, and 8% of all fatalities in the United States in 2017. Following an ischemic attack, inflammatory processes originating from endothelial cells within the brain microvasculature can induce many toxic effects into the impacted area, from both sides of the blood brain barrier (BBB). In addition to increased BBB permeability, impacted brain microvascular endothelial cells can recruit macrophages and other immune cells from the periphery and can also trigger the activation of microglia and astrocytes within the brain. We have identified a key microRNA, let-7g, which levels were drastically diminished as consequence of transient middle cerebral artery occlusion (tMCAO) in vivo and oxygen-glucose deprivation (OGD) in vitro ischemia/reperfusion conditions, respectively. We have observed that let-7g* liposome-based delivery is capable of attenuating inflammation after stroke, reducing BBB permeability, limiting brain infiltration by CD3

Indexed as

Brain IschemiaStrokeAnimalsBlood-Brain BarrierEndothelial CellsInfarction, Middle Cerebral ArteryMiceReperfusionBlood brain barrierIschemia/reperfusionLeukocyte infiltrationmicroRNAStroke

Identifiers

PMID32017988
PMCPMC7316629
OpenAlexW3004069078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.